TrialThe Journal of clinical investigation2020

Oral N-acetylcysteine improves cone function in retinitis pigmentosa patients in phase I trial.

Peter A Campochiaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.